T1	Condition 573 582	infection
T2	Condition-Name 573 582	infection
E1	Condition:T1 Name:T2 Temporality:E36
T3	Condition 682 700	urethral stricture
T4	Condition-Name 682 700	urethral stricture
E3	Condition:T3 Name:T4
T5	Condition 720 738	neurogenic bladder
T6	Condition-Name 720 738	neurogenic bladder
E5	Condition:T5 Name:T6
T7	Condition 630 643	bladder stone
T8	Condition-Name 630 643	bladder stone
E7	Condition:T7 Name:T8
T11	Procedure 179 209	MRI-USG fusion targeted biopsy
T12	Procedure-Name 179 209	MRI-USG fusion targeted biopsy
E11	Procedure:T11 Name:T12
T16	Eq-Operator 77 89	greater than
A1	Eq-Operator-Value T16 GT
T17	Eq-Unit 94 96	cm
T18	Eq-Value 90 93	0.5
T19	Eq-Value 296 297	7
T20	Eq-Value 316 318	20
T21	Eq-Value 376 378	50
T22	Eq-Comparison 77 97	greater than 0.5 cm3
E12	Eq-Comparison:T22 Operator:T16 Value:T18 Unit:T17
T23	Condition 25 45	Visible index lesion
E2	Condition:T23 Name:T24
T24	Condition-Name 25 45	Visible index lesion
T13	Procedure 52 55	MRI
E4	Procedure:T13 Name:T25
T25	Procedure-Name 52 55	MRI
R1	Found-By Arg1:E2 Arg2:E4	
T26	Observation 61 73	Index lesion
E6	Observation:T26 Name:T27 Eq-Comparison:E12
T27	Observation-Name 61 73	Index lesion
A2	Observation-Type-Value T27 measurement
T28	Condition 157 172	prostate cancer
E8	Condition:T28 Name:T29
T29	Condition-Name 157 172	prostate cancer
T30	Modifier 117 126	localized
E10	Modifier:T30 Modifies:T29
T31	Risk 131 135	risk
E13	Risk:T31 Polarity:T32 Risk-For:E8
T32	Polarity 127 130	low
A3	Polarity-Value T32 low
T33	Risk 152 156	risk
E14	Risk:T33 Risk-For:E8 Polarity:T34
T34	Polarity 139 151	intermediate
A4	Polarity-Value T34 medium
T35	Or 136 138	or
E15	Or:T35 Arg:E13 Arg2:E14
T14	Procedure 214 231	saturation biopsy
E16	Procedure:T14 Name:T36
T36	Procedure-Name 214 231	saturation biopsy
T37	Or 210 213	and
E17	Or:T37 Arg:E11 Arg2:E16
T38	Temporal-Connection 173 178	after
E18	Temporal-Connection:T38 Arg:E8 Arg2:E11
A5	Temporal-Connection-Type-Value E18 after
T39	Condition 252 258	tumour
E19	Condition:T39 Name:T40 Stage:E20
T40	Condition-Name 252 258	tumour
T41	Eq-Comparison 259 267	stage T2
E20	Eq-Comparison:T41 Unit:T42 Value:T43
T42	Eq-Unit 259 264	stage
T43	Eq-Value 265 267	T2
T44	Observation 282 295	Gleason score
E21	Observation:T44 Name:T45 Eq-Comparison:E22
T45	Observation-Name 282 295	Gleason score
A6	Observation-Type-Value T45 clinical-score
T46	Eq-Comparison 296 297	7
E22	Eq-Comparison:T46 Value:T19
T47	Or 269 271	or
E23	Or:T47 Arg:E19 Arg2:E21
T48	Observation 312 315	PSA
E24	Observation:T48 Name:T49 Eq-Comparison:E25
T49	Observation-Name 312 315	PSA
A7	Observation-Type-Value T49 lab
T50	Eq-Comparison 316 324	20 ng/ml
E25	Eq-Comparison:T50 Value:T20 Unit:T51 Per:T52
T51	Eq-Unit 319 321	ng
T52	Eq-Unit 322 324	ml
T53	Or 299 301	or
E26	Or:T53 Arg:E21 Arg2:E24
T54	Observation 350 363	Prostate size
E27	Observation:T54 Name:T55 Eq-Comparison:E28
T55	Observation-Name 350 363	Prostate size
A8	Observation-Type-Value T55 measurement
T56	Eq-Comparison 364 381	larger than 50 ml
E28	Eq-Comparison:T56 Operator:T57 Value:T21 Unit:T58
T57	Eq-Operator 364 375	larger than
A9	Eq-Operator-Value T57 GT
T58	Eq-Unit 379 381	ml
T15	Procedure 406 418	contrast MRI
E29	Procedure:T15 Name:T59
T59	Procedure-Name 406 418	contrast MRI
T60	Contraindication 396 401	unfit
E30	Contraindication:T60 Contraindicates:E29
T61	Condition 474 480	cancer
E31	Condition:T61 Name:T62
T62	Condition-Name 474 480	cancer
T63	Procedure 452 461	treatment
E32	Procedure:T63 Temporality:E33
R2	Treatment-For Arg1:E32 Arg2:E31	
T64	Eq-Comparison 443 451	previous
E33	Eq-Comparison:T64 Temporal-Period:T65
T65	Eq-Temporal-Period 443 451	previous
A10	Eq-Temporal-Period-Value T65 past
T66	Procedure 509 516	surgery
E34	Procedure:T66 Name:T67 Temporality:E35
T67	Procedure-Name 509 516	surgery
T9	Modifier 524 532	prostate
E9	Modifier:T9 Modifies:T67
T10	Eq-Comparison 500 508	previous
E35	Eq-Comparison:T10 Temporal-Period:T68
T68	Eq-Temporal-Period 500 508	previous
A11	Eq-Temporal-Period-Value T68 past
T69	Eq-Comparison 552 558	active
E36	Eq-Comparison:T69 Temporal-Period:T70
T70	Eq-Temporal-Period 552 558	active
A12	Eq-Temporal-Period-Value T70 present
T71	Condition 602 619	bladder pathology
E37	Condition:T71 Name:T72
T72	Condition-Name 602 619	bladder pathology
T73	Condition 656 662	cancer
E38	Condition:T73 Name:T74
T74	Condition-Name 656 662	cancer
T75	Or 644 647	and
E39	Or:T75 Arg:E7 Arg2:E38
R3	Example-Of Arg1:E7 Arg2:E37	
R4	Example-Of Arg1:E38 Arg2:E37	
T76	Condition 746 769	sphincter abnormalities
E40	Condition:T76 Name:T77
T77	Condition-Name 746 769	sphincter abnormalities
T78	Or 739 745	and/or
E41	Or:T78 Arg:E5 Arg2:E40
T79	Modifier 648 655	bladder
E42	Modifier:T79 Modifies:T74
T80	Modifier 559 572	urinary tract
E43	Modifier:T80 Modifies:T2
T81	Modifier 465 473	prostate
E44	Modifier:T81 Modifies:T62
